NMNH Cov Khoom Siv Ntxiv: Cov Formulators Yuav Tsum Xav Li Cas?

Dab tsi yuav tsum Formulators xav txogtxog NMNH?

Yam tseem ceeb rau xaiv High{0}}Quality NMNH Powder Raw Materials

• Cov ntaub ntawv raw khoom thiab Crystal Form xaiv

NMNH Powder (Txo Nicotinamide Mononucleotide Powder), NAD + cov khoom xyaw ua ntej, yog qhov rhiab heev hauv nws daim ntawv dawb acid. Yog li ntawd, nws yog feem ntau muab los ua cov ntsev ruaj khov, xws li NMNH disodium ntsev hmoov lossis calcium ntsev. Ntawm cov ntaub ntawv no, NMNH disodium ntsev tau txais kev saib xyuas zoo vim nws txhim kho kev ruaj ntseg thiab kev siv peev xwm.

NMNH disodium ntsev muaj nyob rau hauv ntau cov ntaub ntawv siv lead ua, suav nrog Daim Ntawv A, B, C, D, thiab E, nrog rau daim ntawv amorphous. Cov qauv siv lead ua sib txawv tuaj yeem cuam tshuam rau kev ruaj ntseg, solubility, noo noo rhiab heev, thiab flowability ntawm bulk NMNH hmoov.

Cov kev tshawb fawb qhia tias Crystal Form A muab qhov zoo tshaj plaws kev ruaj ntseg tag nrho. Raws li daim ntawv monohydrate nrog kwv yees li 4% -13% dej cov ntsiab lus, Crystal Form A pom tias muaj kev hloov pauv purity tsawg heev thaum lub sijhawm ntsuas kev ruaj ntseg. Tom qab cia ntawm 25℃thiab 65% txheeb ze av noo rau 5 hnub, purity tsuas yog txo me ntsis los ntawm 99.33% mus rau 99.01%. Hauv kev sib piv, daim ntawv amorphous pom cov dej tsis zoo, ua nplaum thiab oily tom qab ib hnub nyob rau hauv tib yam mob.

Crystal Forms B thiab C feem ntau yuav dhau los ntawm cov dej noo-vim kev hloov pauv mus rau Crystal Form A. Qhov no qhia tau tias NMNH raw cov ntaub ntawv muab rau hauv cov ntaub ntawv siv lead ua tsis ruaj khov yuav tsum tau tswj cov av noo nruj thaum lub sijhawm khaws cia thiab tsim. Uncontrolled crystal transformation yuav cuam tshuam cov khoom sib xws thiab zoo.

Rau cov tuam txhab siv high -purity NMNH hmoov nyob rau hauv cov khoom noj khoom haus los yog cov khoom ua haujlwm, nws raug nquahu kom qhia ib daim ntawv siv lead ua ruaj khov, zoo dua Crystal Form A lossis daim ntawv pov thawj sib npaug. Cov neeg muag khoom yuav tsum muab cov ntaub ntawv txhawb nqa zoo, suav nrog cov qauv XRPD, ntsuas dej noo, ntsuas kev ua kom huv, thiab ua tiav NMNH Powder COA.

• Chemical Stability thiab Storage Requirements

Qhov txo qis pyridine nplhaib qauv ntawm NMNH pab txhawb rau nws txoj haujlwm NAD + ua ntej tab sis kuj nce oxidation rhiab heev. Thaum lub sij hawm cia, NMNH tuaj yeem maj mam oxidize rau hauv NMN, uas yuav cuam tshuam rau cov khoom xyaw nquag thiab cov khoom sib xws.

Txhim khu NMNH hmoov cov neeg muag khoom yuav tsum muab cov ntaub ntawv oxidation stability thiab cov lus pom zoo cia. Kev tiv thaiv kev ntim khoom, suav nrog nitrogen flushing, lub teeb -cov thawv ntim khoom tiv thaiv, thiab ya raws- tswj ntim, tuaj yeem pab tswj kom muaj NMNH purity.

Rau cov tuam txhab tsim khoom ntxiv thiab cov chaw tshawb fawb, xaiv qhov ruaj khov NMNH cov khoom siv raw khoom nrog kev tswj xyuas nruj, kev tshuaj ntsuam xyuas, thiab cov kev daws teeb meem OEM yog qhov tseem ceeb rau kev tsim cov khoom raws li NMNH-.

Kev txiav txim siab tseem ceeb hauv NMNH Powder Supplement Formulation Design

Thaum tsim NMNH hmoov tshuaj, cov tuam txhab lag luam yuav tsum xav txog kev xaiv ntau npaum li cas, kev sib raug zoo ntxiv, thiab ntau npaum li cas. Raws li cov khoom xyaw NAD + boosters, NMNH (Txo Nicotinamide Mononucleotide) muaj peev xwm muaj zog hauv kev tsim khoom noj khoom haus, tab sis nws txoj kev ruaj ntseg yuav tsum tau ua tib zoo tswj thaum lub sij hawm tsim khoom.

• Xaiv daim ntawv xaiv: Khoom vs. kua

NMNH hmoov muaj dej solubility zoo, kwv yees li 44 g / L; Txawm li cas los xij, ib puag ncig aqueous tuaj yeem ua kom nws cov oxidation thiab hloov mus rau NMN. Yog li ntawd, kua formulations xws li kev daws qhov ncauj thiab dej haus ua haujlwm yuav tsum tau xav txog kev ruaj ntseg ntxiv. Dissolved oxygen, hlau ions, thiab lwm yam oxidation-cov khoom txhawb nqa tuaj yeem cuam tshuam qhov ruaj khov ntawm NMNH raw khoom.

Rau feem ntau daim ntawv thov, NMNH tsiav tshuaj thiab cov ntsiav tshuaj yog cov ntawv ntau npaum li cas. Capsule plhaub tuaj yeem txo qhov raug ncaj qha rau huab cua thiab noo noo, pab tiv thaiv siab -purity NMNH hmoov thaum khaws cia. Rau cov ntsiav tshuaj ntau lawm, qhuav granulation los yog compression ncaj qha feem ntau pom zoo vim tias cov txheej txheem no txo ​​qis cov dej noo piv nrog ntub granulation.

Kev sib piv thiab kev tshuaj xyuas ntawm cov ntawv sau ntau npaum li cas

• Excipient Compatibility rau NMNH Formulations

Vim yog txo cov khoom ntawm NMNH, xaiv cov khoom tsim nyog yog qhov tseem ceeb. Formulators yuav tsum tsis txhob oxidizing excipients, peroxide-cov ntaub ntawv, thiab taug qab hlau cov kab mob uas yuav ua rau kom degradation. Pom zoo excipients muaj xws li microcrystalline cellulose ua ib tug muab tub lim, silicon dioxide raws li ib tug txaus tus neeg sawv cev, thiab sodium stearyl fumarate raws li ib tug lubricant lwm txoj rau magnesium stearate.

Rau cov ntsiav tshuaj coated, noo noo- cov ntaub ntawv txheej tiv thaiv tuaj yeem muab kev tiv thaiv ntxiv thiab txhim kho txee ruaj khov ntawm NMNH cov khoom xyaw ntxiv.

• NMNH Dosage Design and Clinical Data

Tib neeg cov kev tshawb fawb soj ntsuam ntawm NMNH calcium ntsev tau soj ntsuam cov koob tshuaj txhua hnub ntawm 125 mg, 250 mg, thiab 500 mg, uas qhia tau tias muaj kev nyab xeeb zoo thiab ua rau ntev tshaj 90 hnub. NAD + qib kev tshuaj ntsuam pom pom qhov koob tshuaj - nyob ntawm qhov nce ntxiv, nrog kev noj NMNH ntau dua ua rau ntau dua NAD + nce.

Cov txiaj ntsig no qhia NMNH kev tsim tshuaj ntsiav tshuaj thiab kev tsim qauv ntxiv. Rau cov khoom lag luam tsom qhov tseem ceeb ntawm NAD + kev txhim kho, ib qho tshuaj ntsiav uas muaj tsawg kawg yog 125 mg NMNH yuav raug txiav txim siab. Split- cov tshuaj formulations, xws li ob lub tshuaj ntsiav uas muaj 62.5 mg ib hnub twg, kuj tseem raug soj ntsuam hauv kev tshawb fawb soj ntsuam.

Kev txwv tsis pub dhau los ntawm Metabolic yam ntxwv ntawm NMNH Powder Formulation Design

NMNH Powder yog suav tias yog tom ntej - tiam NAD + precursor nrog cov yam ntxwv metabolic uas txawv ntawm NMN Powder ib txwm muaj. Tsis zoo li NMN, uas feem ntau hloov mus rau hauv NAD + los ntawm NMNAT txoj hauv kev, NMNH metabolism ua raws cov kev sib txawv uas tsis muaj kev ywj pheej ntawm NRK thiab NAMPT. Kev tshawb fawb qhia tias NMNH yuav tsis tsuas yog nce cellular NAD + qib tab sis tseem cuam tshuam cov txheej txheem metabolic, suav nrog glycolysis, lub voj voog tricarboxylic acid (TCA), thiab antioxidant-txog txoj hauv kev xws li glutathione metabolism.

Rau cov tuam txhab tsim NMNH cov khoom xyaw ntxiv, cov khoom siv metabolic no yuav tsum tau ua tib zoo txiav txim siab thaum tsim qauv. Txij li thaum NMNH tuaj yeem tswj hwm ntau txoj hauv xov tooj ntawm tes dhau ntawm NAD + ntxiv, sib txuas cov purity NMNH Powder nrog lwm cov kev hloov pauv hauv metabolic, xws li glycolysis inhibitors lossis cov khoom xyaw ua haujlwm zoo sib xws, yuav tsum tau soj ntsuam kev sib raug zoo. Kev tshawb fawb hauv vitro thiab kev sim tshuaj tuaj yeem pab txheeb xyuas qhov muaj peev xwm ntxiv lossis cov teebmeem antagonistic. Tsim NMNH raws li cov khoom muaj nyob ib leeg tuaj yeem txo cov kev sib cuam tshuam thiab ua kom yooj yim txhim kho cov khoom lag luam.

NMNH Hmoov Ua Raws Li Kev Ua Lag Luam thiab Kev Lag Luam Kev Lag Luam

Piv nrog rau cov paub tab NAD + precursors xws li NMN, NMNH raw cov ntaub ntawv tam sim no muaj tsawg tsim txoj kev tswj hwm thoob ntiaj teb. Cov tuam txhab tsim cov khoom lag luam NMNH hmoov yuav tsum ua tib zoo tshuaj xyuas cov kev cai tswj hwm hauv lub hom phiaj ua ntej kev lag luam tawm. Xaiv ib tus neeg paub txog NMNH Powder tus neeg muag khoom nrog cov kev tswj xyuas zoo, cov ntaub ntawv qhia kev, thiab kev txhawb nqa kev tswj hwm tuaj yeem pab txo qis kev pheej hmoo ntawm kev ua raws cai.

Rau cov chaw tsim khoom noj khoom haus, cov kev txiav txim siab tseem ceeb suav nrog cov ntaub ntawv raw khoom, cov ntaub ntawv kev nyab xeeb, kev kuaj xyuas zoo, thiab kev ua lag luam- kev soj ntsuam tshwj xeeb. Cov kev cai ua raws cai rau NMNH cov khoom yuav sib txawv ntawm cov cheeb tsam, ua rau kev tswj hwm kev npaj ua ntej tseem ceeb.

Ib lub tswv yim zoo rau cov tuam txhab tsim NMNH hmoov rau cov khoom noj khoom haus yog pib kev soj ntsuam kev lag luam hauv cov cheeb tsam nrog txoj hauv kev kom pom tseeb rau cov khoom noj khoom haus uas tshwm sim thaum khaws cov ntaub ntawv kev nyab xeeb thiab daim ntawv thov. Cov ntaub ntawv no tuaj yeem txhawb nqa cov kev tswj hwm yav tom ntej thiab pab cov tuam txhab tsim khoom ruaj khov, ua raws, thiab kev ua lag luam- npaj NMNH cov qauv.

FAQs:

Q1.Dab tsi yog NMNH hmoov siv raunyob rau hauv kev noj haus formulations?

NMNH (txo nicotinamide mononucleotide) yog ib qho kev txo qis ntawm nicotinamide mononucleotide txuam nrog NAD⁺ metabolism. Supplement formulators yuav tsum soj ntsuam NMNH hmoov rau purity, tshuaj stability, solubility, cia yuav tsum, thiab compatibility nrog rau lwm cov khoom xyaw ua ntej muab tso rau hauv capsules, ntsiav tshuaj, hmoov, los yog lwm yam tshuaj.

Q2. Cov kws tsim qauv yuav tsum xav txog dab tsi thaum xaiv NMNH cov khoom xyaw ntxiv?

Thaum xaiv NMNH cov khoom xyaw ntxiv, cov neeg tsim khoom yuav tsum ntsuas HPLC purity, txheeb xyuas, cov ntsiab lus noo noo, impurity profile, batch sib xws, thiab cov ntaub ntawv ruaj khov. Ib tus neeg muab kev ntseeg siab yuav tsum muab Daim Ntawv Pov Thawj Kev Ntsuam Xyuas (COA), cov kev qhia tshwj xeeb, cov lus pom zoo cia, thiab cov ntaub ntawv muaj txiaj ntsig zoo los txhawb cov khoom tsim nyog.

Q3. Dab tsi purity theem yuav tsum NMNH hmoov ntsib rau kev tsim khoom ntxiv?

Qhov yuav tsum tau NMNH hmoov purity nyob ntawm lub hom phiaj npaj, siv cov cai, thiab cov khoom specifications. Cov kws tsim qauv yuav tsum tsim kom muaj cov qauv kev lees paub raws li cov txheej txheem tshuaj ntsuam xyuas, xws li HPLC, thiab txheeb xyuas txhua pawg tawm tsam cov lus pom zoo. High purity ib leeg tsis tsim kom muaj tag nrho cov khoom zoo lossis ua tiav - khoom ruaj khov.

Q4. Puas yog NMNH hmoov ruaj khov thaum lub sijhawm tsim khoom ntxiv?

NMNH kev ruaj ntseg tuaj yeem cuam tshuam los ntawm cov pa oxygen, noo noo, kub, lub teeb, thiab cov qauv tsim. Cov neeg tsim khoom yuav tsum tshuaj xyuas cov ntaub ntawv ruaj khov thiab ntsuas qhov muaj peev xwm degradation thaum sib xyaw, granulation, compression, thiab ntim. Cov txheej txheem- kev ntsuas tshwj xeeb tuaj yeem pab txheeb xyuas cov xwm txheej uas khaws NMNH zoo thoob plaws hauv kev tsim khoom thiab khaws cia.

Q5. Yuav ua li cas cov formulators txhim kho NMNH hmoov stability?

Txhawm rau txhim kho NMNH cov khoom muaj kev ruaj ntseg, cov qauv tsim yuav tsum tswj cov av noo, txo qis qhov tsis tsim nyog rau cov pa oxygen thiab cua sov, thiab xaiv cov ntim khoom tsim nyog. Antioxidants, stabilizers, lossis kev tiv thaiv kev xa khoom yuav tsum raug soj ntsuam los ntawm kev tshawb fawb txog kev sib raug zoo es tsis xav tias yuav ua tau zoo. Kev nrawm nrawm thiab ntev - kev ntsuas kev ruaj ntseg tuaj yeem pab tsim kom muaj cov qauv tsim nyog thiab khaws cia.

Q6. Lub solubility ntawm NMNH yog dab tsi, thiab vim li cas nws thiaj li tseem ceeb hauv kev tsim qauv?

NMNH solubility cuam tshuam cov khoom sib cais, kev ua haujlwm, koob tshuaj sib xws, thiab kev txhim kho cov kua lossis hmoov- raws li cov tshuaj ntxiv. Formulators yuav tsum sim soj ntsuam cov solubility nyob rau hauv lub npaj pH, kub, thiab hnyav tej yam kev mob. Lawv kuj yuav tsum paub qhov txawv qhov tseeb ntawm kev sib cais los ntawm dispersion thiab ntsuam xyuas seb cov khoom puas tseem nyob ruaj khov thaum npaj.

Q7. Daim ntawv npaum li cas thiaj haum rau NMNH cov khoom xyaw ntxiv?

Cov ntaub ntawv muaj peev xwm ntau npaum li cas rau NMNH suav nrog cov tshuaj ntsiav, ntsiav tshuaj, hmoov sib tov, thiab cov tshuab xa khoom tshwj xeeb, raws li cov khoom tsim nyog thiab cov kev cai tswj xyuas. Kev xaiv nyob ntawm lub hom phiaj ntau npaum, excipient compatibility, ya raws rhiab heev, raug tej yam kev mob, thiab ntim peev xwm. Txhua daim ntawv ntau npaum yuav tsum tau kuaj kom tsim nyog rau cov ntsiab lus sib xws, ruaj khov, thiab cov khoom zoo.

Q8. Cov kws tsim qauv yuav ntsuas NMNH kev sib raug zoo nrog cov khoom ntxiv li cas?

NMNH cov kev tshawb fawb txog kev sib raug zoo yuav tsum tshuaj xyuas kev sib cuam tshuam nrog cov khoom ntim, cov khoom sib khi, cov khoom sib cais, cov roj nplaum, cov ntaub ntawv txheej, thiab lwm yam khoom xyaw. Cov ntsiab lus noo noo, pH, ua haujlwm kub, thiab cov khoom tsis huv tuaj yeem cuam tshuam cov tshuaj lom neeg ruaj khov. Kev tshuaj ntsuam binary compatibility ua raws li cov qauv qauv kev sim tuaj yeem pab txheeb xyuas qhov kev pheej hmoo degradation ua ntej scale - nce.

Xaus:

NMNH muaj peev xwm muaj peev xwm ua tau tom ntej - tiam NAD + ua ntej, tab sis kev tsim ua tiav yog nyob ntawm kev xaiv cov ntaub ntawv siv lead ua ruaj khov, zoo dua Crystal Form A, tswj cov dej noo thiab oxidation, thiab xaiv cov tshuaj tiv thaiv xws li tshuaj ntsiav lossis qhuav - cov ntsiav tshuaj compressed. Excipient compatibility, kev tsim ntau npaum li cas, thiab kev npaj kev tswj hwm yog qhov tseem ceeb sib npaug. Los ntawm kev koom tes nrog cov neeg muag khoom txhim khu kev qha thiab siv cov kev tswj xyuas nruj, cov tuam ntxhab tuaj yeem txhim kho ruaj khov, ua tau zoo, thiab ua raws li NMNH cov khoom ntxiv. Guanjie Biotech muab bulk NMNH Powder daws rau ntiaj teb no nutraceutical manufacturers. Peb muab siab -NMNH hmoov zoo nrog OEM thiab ODM kev pabcuam. Txais tos kom nug nrog peb ntawminfo@gybiotech.com.

Cov ntaub ntawv:

[1] Zapata-Pérez, R., Tammaro, A., Schomakers, BV, et al. (2021). Txo cov nicotinamide mononucleotide yog ib qho tshiab thiab muaj zog NAD + ua ntej hauv cov hlwb thiab nas. FASEB Journal, *35*(4), e21456. https://doi.org/10.1096/fj.202001826R

[2] Li, J., Li, Y., Li, Y., et al. (2026). Kev nyab xeeb thiab kev tshawb nrhiav kev ua tau zoo ntawm Txo -Nicotinamide Mononucleotide Calcium Salt (NMNH-Ca) hauv Noj Qab Haus Huv Nruab Nrab- Cov Neeg Laus thiab Cov Laus: Ib qho Randomized, Ob npaug -Dis muag, Placebo-Tshuaj sim. medRxiv. https://doi.org/10.64898/2026.08.11.26360226

[3] Vinten, KT, et al. (2026). Txo qis dua Oxidized NAD + Precursors Tsav Distinct Transcriptomic, Proteomic, thiab Metabolic Profiles hauv Hepatocytes. FASEB Journal, *40*(4), e71582. https://doi.org/10.1096/fj.202501925R

[4] Yinfu Pharmaceutical Technology (Shanghai) Co., Ltd. (2025). Amorphous daim ntawv ntawm txo -nicotinamide mononucleotide calcium ntsev, nws txoj kev npaj, thiab nws siv. Suav invention patent, CN119978042A.